Background. T-helper (Th) 17 cells are important in the control of Streptococcus pneumoniae. We sought to understand the mechanism of failure of Th17 immunity resulting in S. pneumoniae infections in children <2 years old.
Infants and young children <2 years of age experience frequent infections by Streptococcus pneumoniae, resulting in about 11% of all deaths in children [1, 2] . CD4 + T-cell responses have been shown to be a correlate of protection against S. pneumoniae nasopharyngeal (NP) colonization in mice [3] [4] [5] , human adults [6, 7] , and children as young as 5 years old [8, 9] . Specifically, T-helper (Th) 1 and Th17 cells are known to play an important role in S. pneumoniae clearance from the mouse NP through secretion of interferon (IFN) γ, interleukin 2 (IL-2), tumor necrosis factor (TNF) α (Th1), and interleukin 17 (IL-17) (Th17) [4, 10] . Interleukin 12p70 promotes the differentiation of CD4 + T cells into Th1, and interleukin 6 (IL-6), interleukin 1β (IL-1β), interleukin 23 (IL-23), and transforming growth factor (TGF) β together promote Th17 differentiation [11] [12] [13] . Interleukin 12 promotes Th1 differentiation through activation of signal transducer and activator of transcription factor (STAT) 4, promoting IFN-γ production, which in turn enhances chemokine expression and neutrophil recruitment, improving protection against S. pneumoniae infection [11, 14] . The innate cytokines IL-6, IL-1β, and IL-23 promote Th17 differentiation by abrogating expression of retinoic acid-mediated forkhead box protein 3 (Foxp3) and increasing phosphorylation of STAT3 (pSTAT3 Y705) [15, 16] . pSTAT3 increases the expression of IL-23R and transcription factor retinoic acid receptor-related orphan receptor Πt (ROR-γt), promoting the expression of IL-17 family genes, IL17A, IL17F, IL21, and IL23 [17, 18] .
A study in children aged 5-7 years demonstrated that low S. pneumoniae NP carriage density is associated with heightened Th17 immunity [9] . Furthermore, memory Th17 cell responses in human NP-associated lymphoid tissue were associated with S. pneumoniae NP clearance in children 2-12 years old [19] . Although these study findings demonstrate a role of Th17 immunity and its association with protection against S. pneumoniae NP colonization in adults and older children, children <2 years of age have not been studied, although they are especially prone to pneumococcal infections [2, 8] . About 80% of children experience ≥1 episode of acute otitis media (AOM) during the first 2 years of life, and about 30% experience ≥3 episodes within a 6-to 12-month time span (these children are termed "infection prone" in the current study) [8, 20, 21] . In our studies we have described immature, neonatal-like immune responses in children prone to frequent S. pneumoniae AOM infections [22] .
We investigated the mechanism of an identified deficiency of Th17 responses in infection-prone (IP) children because of their dominant role in protection against S. pneumoniae infections [4, 7, 9, [23] [24] [25] . By stimulating peripheral blood mononuclear cells (PBMCs) of IP children with heat-killed (HK) S. pneumoniae, we were able to show that IP children have reduced proliferation and differentiation of IL-17A + CD4 + T cells compared with non-IP (NIP) children. Therefore, we sought to determine whether the cellular defects in IP children were due to impaired pro-Th17 cytokine production upstream by their antigen-presenting cells. We found that the PBMCs from children prone to infection with S. pneumoniae produced significantly lower amounts of pro-Th17 cytokines in response to HK S. pneumoniae than PBMCs from NIP children. Addition of pro-Th17 cytokines restored CD4 + Th17 cell function to levels measured in NIP children.
METHODS

Subjects
Subjects were part of a prospective, longitudinal study of immunologic dysfunction in children 6-36 months old prone to middle-ear infection (otitis). Details of the study population demographics have been published elsewhere [21, 26] . Parents of all subjects (aged 9-18 months old; mean age, 14 months) provided written informed consent. Every clinical diagnosis of AOM was microbiologically confirmed by culture of middle-ear fluid obtained by tympanocentesis. Children who experienced ≥3 AOM episodes within 6 months or ≥4 AOM episodes within 12 months are categorized as IP in this report. As a control group, we studied NIP children who experienced ≤2 AOM episode during the study period. In our study design, AOM caused by S. pneumoniae was reliably identified from the otherwise sterile middle-ear space, making this an ideal infection to identify children for the experiments undertaken. All of the children in our study population received Prevnar-13 vaccine (Pfizer)
Cell Isolation and Stimulation
The PBMCs were thawed and revived in cell culture medium Roswell Park Memorial Institute 1640 medium plus L-glutamine supplemented with 10% heat-inactivated fetal bovine serum (Fisher Scientific), 10 µg/mL DNase (Sigma-Aldrich), penicillin (50 IU/mL)-streptomycin (50 µg/mL) (Gibco), and 50 µmol/L β-mercaptoethanol (Sigma-Aldrich). Cell viability was tested by trypan blue dye exclusion, and 1-2 × 10 6 cells per well in 250 µL of cell culture medium lacking DNase were plated into a 96-well round-bottom plate (BD). Briefly, PBMCs (1 × 10 6 per well) were stimulated with HK culture of S. pneumoniae 6B strain (HK S. pneumoniae; 1 × 10 8 colony-forming units [CFUs]/mL), prepared as described elsewhere [27, 28] . After 2 hours, Golgi transport inhibitors (brefeldin A and monensin; BD Biosciences) were added and continued for an additional 16 hours at 37°C in 5% carbon dioxide. Unstimulated PBMCs were also evaluated as controls of basal cytokine production and cell-surface marker expression.
Flow Cytometric Analysis
Stimulated PBMCs were labeled with antibodies for cell-surface markers: anti-CD3 conjugated to Pacific Blue (clone UCHT1), anti-CD4 phycoerythrin (PE)-Texas Red (clone RPA-T4), anti CD8a PE cyanine (Cy) 5 (clone RPAT8), anti CD69 antigenpresenting cells (clone FN50), and anti-CD45RA fluorescein isothiocyanate (clone MEM-56) [29] . For intracellular staining assay, the cells were permeabilized with 1× permeabilization buffer (eBiosciences) and stained with anti-IFN-γ PE-Cy7 (clone 4S.B3), anti-IL-2 Alexa Fluor700 (clone MQ1-17H12), anti-TNF-α peridinin-chlorophyll protein Cy5.5 (clone Mab11), anti-interleukin 4 PE (clone 8D4-8), and anti-IL-17A PE Cy7 (clone BL168). After 3 washes with 1× permeabilization buffer cells were fixed with 2% paraformaldehyde and collected with doublet discrimination using a BD LSR II flow cytometer (BD Biosciences). Data were analyzed using FlowJo software, version 10.1 (TreeStar).
Cytokine Assays
For cytokines in cell culture supernatant, PBMCs (1 × 10 6 cells per well) were stimulated with HK S. pneumoniae (1 × 10 8 CFUs per well) for 72 hours at 37°C, as described elsewhere [28] . The cells were centrifuged, and supernatants were collected and saved at −80°C. On the day of assay, cell culture supernatants and the NP secretions (stored at −80°C) were thawed at room temperature, and total cytokines were measured using a BioPlex Pro Human Cytokine Group-I 12-plex assay kit (Bio-Rad), according to the manufacturer's instructions.
HK S. pneumoniae-Induced Proliferation of IL-17 + T Cells
To determine whether HK S. pneumoniae induced proliferative responses, PBMC cultures were labeled with 5 µmol/L carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes) and stimulated with HK S. pneumoniae, alone or with pro-Th17 cytokines (10 ng/mL IL-6, IL-1β, and IL-23 and 1 ng/mL TGF-β; all from eBiosciences) for 5 days at 37°C in 5% carbon dioxide. On day 6 of the assay pneumococcal-induced proliferating cells (CFSE low ) were evaluated among CD4 + IL-17-producing cells. These PBMCs were further stimulated with phorbol myristate acetate and ionomycin for 2 hours and an additional 6 hours with Golgi transport inhibitors, as described above, and stained with anti-CD3, anti-CD4, antiCD8a, and anti-IL-17A antibodies.
Phosphospecific Flow Cytometric Analysis
PBMCs (1 × 10 6 cells in 150 μL per well) were stimulated with HK S. pneumoniae (1 × 10 7 CFUs per well) in the presence or absence of pro-Th17 cytokines (10 ng/mL IL-6, IL-1β, and IL-23 and 1 ng/mL TGF-β) for 15 minutes at 37°C. Unstimulated cells were taken as controls in both conditions. Equal volumes of intracellular fixation buffer were added and incubated for 30 minutes on ice. The cells were permeabilized in ice-cold methanol for 30 minutes on ice, washed 3 times in flow cytometry staining buffer, and stained with fluorophore-specific antibodies anti-CD3, anti-CD4, and anti-STAT3 (pY705) (eBiosciences) for 30 minutes at room temperature. Cells were washed, resuspended in 200 μL of staining buffer, and analyzed with an LSR II flow cytometer.
RNA Extraction and Quantitative Real-Time Polymerase Chain Reaction
PBMCs stimulated with HK S. pneumoniae (1 × 10 8 CFUs per well) for 72 hours at 37°C were collected in RNAlater solution (Sigma-Aldrich), and RNA was extracted using the Qiagen RNeasy Mini kit (Qiagen Biosciences). Total RNA (1.0 mg) was reverse-transcribed into complementary DNA and loaded on the Human Th17 RT 2 Profiler-PCR Array (PAHS-073; SABiosciences). Polymerase chain reaction (PCR) amplification was performed according to the manufacturer's guidelines. Only genes with threshold cycle (C t ) values <35 were considered detectable, and C t values of the genes were normalized with the mean C t value of 4 housekeeping genes on the array: β-actin, β2-microglobulin, glyceraldehyde-3-phosphate dehydrogenase, and ribosomal protein large P0. Results are expressed as fold change (2 −ΔΔCt ) relative to unstimulated samples [30] .
Statistical Analysis
Data was analyzed using Graph Pad Prism software (version 6.04) with 2-tailed Student t test and Mann-Whitney U tests (nonparametric data). Differences were considered significant at P < .05. To control for multiple testing, for each analysis adjusted P values were calculated using the Benjamini-Hochberg procedure, which controls for false discovery rate.
RESULTS
Study Population
From the study population, age-matched samples from 20 IP and 20 NIP children <2 years old were used for comparative analysis. No significant differences were found in the frequency of atopic and nonatopic children between the 2 cohorts (P = 1.0) (Supplementary Table 1 ). Among 20 IP children included in the study, 13 had an active infection at the time their PMBCs were sampled; all infections were caused by S. pneumoniae. Among the 20 NIP subjects, 2 were actively infected by S. pneumoniae. Because active infection might modify the immune responses evaluated in our studies, we sought to determine whether responses measured in samples collected during active infection clustered differently than those measured in samples collected when the children were well, with no active infection. Using a statistical linear model (F test) with IP/NIP as the main effect and IP/NIP and health status interaction, we determined that the active infection cohort did not differ significantly in responses from the cohort with no active infection (Supplementary Table 2 ), thereby justifying the pooling of responses from infected and healthy subjects.
Th1 and Th17 Responses to S. pneumoniae Among IP and NIP Children
Previous studies have shown that HK S. pneumoniae enhanced Th1 and Th17 responses by PBMCs [6, 28, 31, 32] . We found that IP children ≤2 years old, compared with NIP children, had a significantly reduced percentage of activated CD4 + T cells producing IL-2, TNF-α (Th1), and IL-17A (Th17) cytokines (P < .001, P = .005, and P = .01 respectively) in response to HK S. pneumoniae stimulation (Supplementary Figure1 and Figure 1A ). There were no differences in the median number of total events acquired or total CD4 + T cells acquired for the assay (Supplementary Figure S2A 
Divergence of Memory Phenotypes of CD4 + T Cells Among IP and NIP
Children
To further assess the CD4 + T-cell defect in IP children, we analyzed the numbers of activated memory cells (CD4 + CD69 + CD45RA − ) after stimulation with HK S. pneumoniae. We found similar proportions of activated memory T cells among IP and NIP children in response to HK S. pneumoniae (Supplementary Figure S2C) . However, the number of memory T cells (CD4 + CD69 + CD45RA − ) producing IFN-γ, IL-2, TNF-α, or IL-17A was significantly less in IP children (Figure 2A and  2B) . Furthermore, we found that the frequencies of naive T cells (CD4 + CD69 + CD45RA + ) producing IL-2 were significantly lower in IP than in NIP children in response to HK S. pneumoniae stimulation ( Figure 2C ).
Divergent Levels of Cytokines in IP Children
Because of proinflammatory cytokines has been shown to be critical for protective immunity against S. pneumoniae infections, we compared extracellular cytokine levels from PBMCs of IP and NIP children in response to HK S. pneumoniae stimulation. As shown in (Figure 3) , IP children produced significantly lower levels of IFN-γ, IL-17A, interleukin 21 (IL-21), and IL-23 than NIP children. Levels of IL-6, IL-2, interleukin 10, TNF-α, TGF-β, and Th2 cytokine (interleukin 4 and interleukin 13 [IL-13]) in the cell culture supernatants were relatively lower in samples from IP children samples than in those from NIP children, but the mean values did not differ significantly. Furthermore, we found significantly lower levels of IL-6 and IL-23 in the NP secretions from IP children than in those from NIP children (Supplementary Figure S4) . [4, 9, 19, 33] . Having observed impaired Th17 responses to a short period of HK S. pneumoniae stimulation in IP children, we sought to determine whether CD4 + T cells of IP and NIP children differed in their proliferation and differentiation after a longer duration of S. pneumoniae stimulation. After 5 days of stimulation with HK S. pneumoniae, there were significantly fewer differentiated Th17 cells in samples from IP than in those from NIP children ( Figure 4A and 4B) . Furthermore, we sought to determine whether CD4 + T cells from IP and NIP children differed in their proliferation after HK S. pneumoniae stimulation. We used CFSE-labeled PBMCs from both groups, stimulated with HK S. pneumoniae for 5 days, and found that IP children showed significantly less proliferation than NIP children among IL-17A + T cells (gated on CD3 + CD4 + IL-17A + ) ( Figure 4C and 4D) . Taken together, these results demonstrate for the first time that PBMCs from IP children are defective in S. pneumoniae-induced Th17 proliferation compared with those from NIP children.
We next sought to determine whether the defect in Th17 lineage differentiation could be restored by addition of exogenous pro-Th17 cytokines. PBMCs were stimulated with HK S. pneumoniae in the absence or presence of pro-Th17 cytokines (IL-6, pneumoniae-Th17) among IP (n = 10) and NIP (n = 10) children for 5 days. IP children showed significant lower IL-17A + CFSE low proliferation responses to HK S. pneumoniae stimulation than did NIP children. P values were calculated using the Mann-Whitney U test, and bar graphs show means with standard errors of the mean. Differences remained significant with adjusted P values for multiple comparisons using the BenjaminiHochberg procedure, with a false discovery rate of <0.05.
IL-1β, IL-23, and TGF-β) for 5 days. Without pro-Th17 cytokines, PBMCs of NIP subjects had significantly higher IL-17A + T-cell responses at 5 days, but the addition of pro-Th17 cytokines restored IL-17A + T-cell responses in the PBMCs from IP children up to levels similar to those from NIP children ( Figure 4D ).
This raised the question of whether there was an intrinsic defect in the Th17 activation pathway in IP children or whether the defect lay upstream, in the production of Th17-promoting innate cytokines. Therefore, PBMCs from IP and NIP children were stimulated with HK S. pneumoniae alone or HK S. pneumoniae with pro-Th17 cytokines (IL-6, IL-1β, IL-23, and TGF-β), and the phosphorylation of STAT3 (pSTAT3) was measured using flow cytometry. HK S. pneumoniae alone resulted in a lower mean fluorescence intensity of pSTAT3 in PBMCs from IP children ( Figure 5A and 5B). However, STAT3 phosphorylation in these PBMCs was increased by the addition of pro-Th17 cytokines along with HK S. pneumoniae ( Figure 5A and 5B), achieving levels similar to those in PBMCs from NIP children.
Gene Expression of Cytokines, Cytokine Receptors and Transcription
Factors
To determine differential gene expression in the signaling pathways for Th17 induction in CD4 + T cells, RNA was isolated from the PBMC cultures stimulated with HK S. pneumoniae. A realtime PCR analysis was performed using human Th17 RT 2 -PCR profiler arrays. As shown in (Figure 6 ), after HK S. pneumoniae stimulation, the expression of IFN-γ, IL-2, IL-13, IL-17A IL-23, and TGF-β was significantly lower in samples from IP children than in those from NIP children. Furthermore, Th1 and Th17 fate-determining transcription factors T-box transcription TBX21, GATA3 , RORC, and Foxp3) among IP (n = 6) and NIP (n = 6) children. Fold change is relative to the level of each gene expressed in peripheral blood mononuclear cells (PBMCs) stimulated with heat-killed Streptococcus pneumoniae versus unstimulated PBMCs. P values were calculated using the Mann-Whitney U test, and bar graphs show means with standard errors of the mean. Differences remained significant with adjusted P values for multiple comparisons using the Benjamini-Hochberg procedure, with a false discovery rate of <0.05, except for GATA-3 (P = .07). Abbreviations: TBX21, T-box transcription factor 21; GATA3, GATA binding protein 3; RORC, RAR-related orphan receptor C; Foxp3; forkhead box protein 3.
factor 21 (TBX21) (Tbet) and RAR-related orphan receptor C (RORC) (ROR-γt) showed lower expression levels in samples from IP children compared with NIP children. In contrast, Foxp3 expression was significantly higher in samples from IP children ( Figure 6 ). No significant differences in the expression of surface antigens, chemokines, cytokines, or transcription factors in unstimulated cells were observed between IP and NIP children (data not shown).
DISCUSSION
Our prior studies in young children prone to recurrent S. pneumoniae infections of the middle ear point toward a prolonged immaturity in immune response resembling a neonatal profile [22] . Neonatal immunity is characterized by an impaired Th1 response and preferential polarization toward a Th2 response and deficient Th17 immunity [34, 35] . To our knowledge, this is the first report of impaired Th1 and Th17 T-cell responses to S. pneumoniae in infants prone to recurrent S. pneumoniae infections. Our findings suggest a major impairment in CD4 + IL-17A + T-cell receptor in the peripheral blood of IP children, which probably contributes to their higher susceptibility to S. pneumoniae infections, including middle-ear infections. We also found that addition of exogenous Th17-promoting cytokines restored CD4 + Th17 cell function in cells from IP children to levels measured in NIP children. This finding has implications because Th1 and Th17 responses play an important role in S. pneumoniae clearance from the NP by secretion of IFN-γ, IL-2, TNF-α, and IL-17 [8] [9] [10] 19] .
Prior studies in adults and older children have shown that IFN-γ-and IL-17-producing CD4 + T-helper cells contribute to protection against infections caused by S. pneumoniae by an antibody-independent mechanism [3, 5, 33] . In this report, we add further evidence regarding CD4 + T-cell deficits among children <2 years old who have experienced recurrent S. pneumoniae infections, demonstrating a functional impairment in secreting Th1 and Th17 cytokines in response to HK S. pneumoniae stimulation. Among CD4 + T-cell subsets, Th17 cells are unique and are characterized by production of IL-17, a highly proinflammatory cytokine that binds to epithelial and endothelial cells, resulting in chemokine production and up-regulation of adhesion molecules, such as CXCL1 and intercellular adhesion molecule 1 [36, 37] . These events ultimately contribute to the recruitment of neutrophils and monocytes to the site of infection [38] . A defect in IL-17A production by CD4 + T cells could affect the level of resistance/protection from NP colonization at which S. pneumoniae pathogenesis commences [4, 6, 9, 24, 25, 39] . In support of this hypothesis, we found a reduced number of activated Th17 cytokine-secreting CD4 + T cells in response to HK S. pneumoniae stimulation in PBMCs from IP children, compared with those from NIP children.
Among all the cytokine-secreting CD4 + T cells tested in our assays, we found that frequencies of TNF-α + CD4 + T cells were highest, followed by IL-2 + CD4 + T cells; IFN-γ + CD4 + T-cell responses were very low compared with other cytokine responses. Previous studies in children aged 1-5 years have demonstrated that the highest percentages of antigen-experienced CD4 + T cells are more likely to have effector memory with low frequency of polyfunctional T cells [40, 41] . In the current study, we observed a lower frequency of memory CD4 + T cells expressing IL-2 and IL-17 cytokines in IP children aged <2 years old. However, the exact mechanism responsible for the limited differentiation of memory CD4 + T cells in IP children has yet to be studied.
Earlier studies have demonstrated that innate cytokines IL-1β, IL-6, IL-21, and IL-23, along with TGF-β, trigger and maintain Th17 development [42] [43] [44] [45] [46] . Furthermore, studies in mouse and human PBMCs have shown that, along with innate cytokines, costimulatory signals involving CD28 or the affinity/ avidity of the peptide/major histocompatibility complex for the T-cell receptor play an important role in the differentiation of Th17 cells [47, 48] . Verhoeven et al [49] demonstrated in previous studies that IP children have significantly lower amounts of innate cytokines IL-6, interleukin 7 and 8, and macrophage inflammatory protein 1b and chemokines CCL28, intercellular adhesion molecule 1, and epithelial-derived neutrophil-activating peptide 78 in their NP secretions. We undertook additional experiments to remeasure the levels of IL-6 and newly measure IL-23 in the NP secretions of IP and NIP children. We observed a significantly lower amount of IL-6 (confirming prior findings) and significantly lower IL-23 cytokine in the nasal secretions of IP compared with NIP children.
In the current studies, we observed reduced pSTAT3 Y705 levels and IL-17 production in response to HK S. pneumoniae stimulation in CD4 + T cells from IP children, compared with those from NIP children, corresponding to lower production of Th17-promoting innate cytokines (specifically IL-6, IL-21, and IL-23). Furthermore, we found that IL-17 production by IP CD4 + T cells could be rescued by the addition of exogenous Th17-promoting cytokines (IL-6, IL-1β, IL-23, and TGF-β), resulting in pSTAT3 Y705 levels and IL-17 + CD4 + T-cell frequencies similar to those in NIP children. From these results, we conclude that the deficits in Th17 responses that we observed in PBMCs are due to the lack of accessory pro-Th17 cytokines required for Th17 differentiation. Because of the limited number of PBMC samples available, we were unable to test whether any individual cytokine will rescue the Th17 phenotype of CD4 + T cells from IP children. Future studies in our laboratory will test the role of individual cytokine in rescuing the Th17 phenotype in PBMCs from IP children.
To determine whether an actual defect existed in the differentiation of IP Th17 cells, we analyzed messenger RNA expression of the master regulatory transcription factors RORC, TBX21, GATA binding protein 3 (GATA3), and Foxp3 in CD4 + T cells stimulated with HK S. pneumoniae. T cells of IP children expressed higher levels of Foxp3 genes and low expression of TBX21 and RORC. Similar to this observation, a recent study in children 3-5 years old has shown that higher expression of Foxp3 + regulatory T cells down-regulates Th17 cells, leading to chronic S. pneumoniae carriage [15, 50] .
In summary, the data from our current study are consistent with a model in which a primary defect in children <2 years old who are prone to infection with S. pneumoniae is a deficiency in production of innate cytokines, including IL-21 and IL-23, which leads to reduced CD4 + T-cell responses in the Th17 lineage. A clear understanding of these mechanisms that regulate Th1 and Th17 cytokines could lead to the development of novel immunomodulatory therapies aimed at reducing infection proneness in children <2 years old.
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